14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 6 May 2024

Trading levels for MBIO

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.318 8.40 %
R2 0.306 4.48 %
R1 0.299 2.07 %
Current price: 0.293
Support S1 0.276 -5.75 %
S2 0.269 -8.17 %
S3 0.258 -12.08 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.346 18.16 %
R2 0.340 16.04 %
R1 0.316 7.88 %
Current price 0.293
Support S1 0.260 -11.23%
S2 0.248 -15.36%
S3 0.237 -19.11%

MBIO Predictions History

2 years ago
RamboRex3000 predicted that MBIO for 2021-08-20 is going $2.60 (-2.62%)

2 years ago
AlexVel predicted that MBIO for 2021-08-20 is going $2.73 (2.25%)

2 years ago
JS predicted that MBIO for 2021-08-20 is going $2.71 (1.50%)

2 years ago
fierrojoe12.251979 predicted that MBIO for 2021-08-20 is going

Rank:

3 years ago
iHustle84 predicted that MBIO for 2020-09-21 is going $3.90 (7.44%)

3 years ago
JS predicted that MBIO for 2020-09-21 is going $3.81 (-1.80%)

3 years ago
BoldBullers predicted that MBIO for 2020-09-21 is going $3.89 (0.26%)

Rank:

4 years ago
Zach Marshall predicted that MBIO for 2020-01-17 is going $3.40 (-21.48%)

Rank:

4 years ago
GoldenNugget predicted that MBIO for 2019-05-07 is going $4.10 (-3.41%)

4 years ago
NameNotImportant predicted that MBIO for 2019-05-06 is going $3.91 (-4.40%)

Click to get the best stock tips daily for free!

About Mustang Bio Inc

Mustang Bio Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors. The company develo... MBIO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT